- Previous Close
5.16 - Open
5.09 - Bid 5.68 x --
- Ask --
- Day's Range
5.08 - 5.68 - 52 Week Range
3.60 - 6.05 - Volume
24,078,197 - Avg. Volume
9,339,483 - Market Cap (intraday)
1.967B - Beta (5Y Monthly) 0.41
- PE Ratio (TTM)
-- - EPS (TTM)
-0.19 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date Jul 9, 2019
- 1y Target Est
--
Baiyang Investment Group, Inc., together with its subsidiaries, operates in the aquaculture industry in China. The company is involved in feed and feed raw materials, aquatic product processing, biological product, ocean fishing, and processing business, as well as aquatic research and development, aquatic fry breeding, feedstuff production, fish farming, and gelatine and other biological products production activities. It offers tilapia, shrimp, and grass carp products; and collagen and gelatin biological products for use in make-up, beverage, healthcare and pharmaceutical fields. The company also supplies frozen tilapia fillets and frozen tilapia; and specializes in the research, development, manufacture, and sale of fish, shrimp, and frog feeds. In addition, it exports its aquatic products to the United States, Latin Amercia, Mexico, Canada, the European Union, the Middle East, and internationally. The company was formerly known as Baiyang Aquatic Group, Inc. and changed its name to Baiyang Investment Group, Inc. in November 2015. Baiyang Investment Group, Inc. was founded in 2000 and is headquartered in Nanning, China.
www.baiyang.com2,906
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 002696.SZ
View MorePerformance Overview: 002696.SZ
Trailing total returns as of 4/11/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 002696.SZ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 002696.SZ
View MoreValuation Measures
Market Cap
1.97B
Enterprise Value
2.03B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.55
Price/Book (mrq)
1.44
Enterprise Value/Revenue
0.71
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-2.32%
Return on Assets (ttm)
-1.43%
Return on Equity (ttm)
-4.42%
Revenue (ttm)
2.87B
Net Income Avi to Common (ttm)
-66.74M
Diluted EPS (ttm)
-0.19
Balance Sheet and Cash Flow
Total Cash (mrq)
621.98M
Total Debt/Equity (mrq)
84.49%
Levered Free Cash Flow (ttm)
-46.5M